Published On: Wed, Apr 3rd, 2019

Roche extends Spark offer after getting 29 percent in tender

Share This
Tags


April 3, 2019

ZURICH (Reuters) – Roche Holding has extended until May 2 its $4.3 billion offer for U.S. gene therapy specialist Spark Therapeutics, the Swiss drugmaker said after getting 29.4 percent of Spark’s shares in a tender originally due to end on Wednesday.

“All terms and conditions of the offer shallremain unchanged during the extended period,” Roche said in a statement on the $114.50 per share offer it announced in February.

(Reporting by Michael Shields, Editing by John Revill)



Source link

About the Author